Abstract:
A connecting structure, standard sections, a channel having the standard sections, and an irrigation system are provided. The standard sections each comprise a bottom plate and side plates fixedly connected to both sides of the bottom plate; the three plates form a standard section body in a groove structure. Two ends of the standard section are respectively provided with a male buckle and a female buckle, or the two ends of the standard section are both provided with the male buckle or the female buckle. The male buckle comprises a male buckle connection plate. The female buckle comprises a female buckle connection plate having a U-shaped groove. Moreover, the thickness of the male buckle connection plate matches the width of the U-shaped groove, in order to prevent the male buckle connection plate from coming out of the U-shaped groove of the female buckle connection plate after being inserted therein.
Abstract:
A process for producing at least one light olefin comprising: (a) contacting a first raw material comprising methanol with a least one catalyst in a first reaction zone to produce at least one light olefin and at least one inactivated catalyst; (b) transporting the at least one inactivated catalyst to a first regeneration zone to produce at least one first regenerated catalyst, and transporting a portion of the at least one first regenerated catalyst to the first reaction zone; (c) transporting another portion of the at least one first regenerated catalyst to a second regeneration zone to obtain at least one second regenerated catalyst; and (d) transporting the at least one second regenerated catalyst to a second reaction zone, and contacting the at least one second regenerated catalyst with a second raw material comprising C4 olefins to produce a product stream II comprising at least one light olefin.
Abstract:
Phosphorus-containing group-substituted quinolines of formula (I) are provided in the present invention. The preparation process and application of the compound, and formulation comprising phosphorus-containing group-substituted quinolines are also disclosed. The compounds are protein kinase inhibitor and can be used for treating protein kinase abnormal activity-associated diseases, such as tumor, etc.
Abstract:
A process for producing at least one light olefin comprising: (a) contacting a first raw material comprising methanol with a least one catalyst comprising at least one silicon-aluminophosphate molecular sieve in a first reaction zone to produce a product stream I comprising at least one light olefin and at least one inactivated catalyst; (b) transporting the at least one inactivated catalyst to a first regeneration zone to produce at least one first regenerated catalyst, and transporting a portion of the at least one first regenerated catalyst to the first reaction zone, wherein the at least one first regenerated catalyst comprises a carbon deposit present in an amount ranging from about 0.8% to about 2.5% by weight relative to the total weight of the at least one first regenerated catalyst; (c) transporting another portion of the at least one first regenerated catalyst to a second regeneration zone to obtain at least one second regenerated catalyst, wherein the at least one second regenerated catalyst comprises a carbon deposit present in amount of less than about 0.2% by weight relative to the total weight of the at least one second regenerated catalyst; and (d) transporting the at least one second regenerated catalyst to a second reaction zone, and contacting the at least one second regenerated catalyst with a second raw material comprising C4 olefins to produce a product stream II comprising at least one light olefin.
Abstract:
Provided in the present invention is a quinolyl-containing hydroxamic acid compound as shown in formula (I), at the same time also disclosed is the preparation method of the compound and the use thereof, and a pharmaceutical composition containing the quinolyl-containing hydroxamic acid compound. Such compounds are inhibitors of protein kinases and/or histone deacetylases, and can be used in the treatment of diseases caused by the abnormal activity of protein kinases and/or histone deacetylases, for example, tumors, etc.
Abstract:
A linear actuator includes a stationary part, a movable part moveably supported by the stationary part, and at least one elastic member disposed between the movable part and the stationary part. The stationary part includes a stator core with a pair of teeth extending inwardly there from, and a winding wound on each of the teeth. The movable part disposed between the teeth includes two pairs of permanent magnetic poles respectively facing the teeth and an output shaft projecting in a first direction. When the windings are electrified, the stationary part generates a magnetic field which interacts with the permanent magnetic poles to reciprocate the movable part relative to the stationary part in a second direction perpendicular to the first direction.
Abstract:
The present invention discloses a nitropyridinyl ethyleneimine compound as shown in the formula I and a preparation method of the same, as well as use of the compound in manufacture of a prodrug and in manufacture of a drug for treating a tumor.
Abstract:
A catalyst component for ethylene polymerization, comprising an organic silicon compound of the formula (I), below wherein R1 is chosen from C3-C20 aliphatic hydrocarbyl groups, and is substituted with at least one substituent chosen from halogens, C1-C6 acyloxy groups, epoxy, amino, C1-C6 alkylamino groups, di(C1-C6 alkyl)amino groups, C1-C6 alkoxy groups, and oxo group; R2, R3 and R4, which may be the same or different, are each chosen from C1-C10 aliphatic hydrocarbyl, C3-C10 alicyclic hydrocarbyl, C6-C10 aryl, C7-C10 aralkyl, and C7-C10 alkaryl groups. A process for preparing the catalyst component and an active catalyst comprising the catalyst component and useful in polymerization, such as ethylene polymerization.
Abstract:
The present invention provides a catalyst component for ethylene polymerization, a process for preparing the same, a catalyst comprising the same, and a process for polymerizing ethylene using the catalyst. The catalyst component comprises a reaction product, supported on an inorganic oxide support, of a magnesium complex, a titanium compound, an alcohol compound, and an organoaluminum compound, wherein said magnesium complex is formed by dissolving a magnesium halide in a solvent system comprising an organic epoxy compound and an organo phosphorus compound. The catalyst according to the invention is especially suitable for slurry phase polymerization of ethylene. The catalyst according to the present invention has high catalytic activity, and a good hydrogen response, with the resultant polymer having a more uniform particle size diameter and a narrow particle size distribution.
Abstract:
Provided in the present invention is a quinolyl-containing hydroxamic acid compound as shown in formula (I), at the same time also disclosed is the preparation method of the compound and the use thereof, and a pharmaceutical composition containing the quinolyl-containing hydroxamic acid compound. Such compounds are inhibitors of protein kinases and/or histone deacetylases, and can be used in the treatment of diseases caused by the abnormal activity of protein kinases and/or histone deacetylases, for example, tumors, etc.